• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在为患有玻璃体视网膜疾病和青光眼的儿科患者进行玻璃体切割术时进行睫状体眼内光凝术。

Ciliary body endophotocoagulation during pars plana vitrectomy for pediatric patients with vitreoretinal disorders and glaucoma.

作者信息

Sears J E, Capone A, Aaberg T M, January B

机构信息

Emory Eye Center, Emory University School of Medicine, Atlanta, Georgia 30322, USA.

出版信息

Am J Ophthalmol. 1998 Nov;126(5):723-5. doi: 10.1016/s0002-9394(98)00184-6.

DOI:10.1016/s0002-9394(98)00184-6
PMID:9822240
Abstract

PURPOSE

To investigate the efficacy of ciliary body endophotocoagulation during pars plana vitrectomy in eyes of pediatric patients with medically uncontrolled glaucoma.

METHOD

We compared preoperative and postoperative intraocular pressure and visual acuity in five eyes of five patients aged between 10 months and 14.5 years who had 180 degrees of ciliary body endophotocoagulation with pars plana vitrectomy.

RESULTS

Preoperative intraocular pressure on medical therapy for glaucoma ranged from 30 to 55 mm Hg (median, 35 mm Hg). Postoperative follow-up ranged from 12 to 24 months, with a median of 16 months. Postoperative intraocular pressure on medical therapy ranged from 12 to 35 mm Hg (median, 25 mm Hg) at 6 weeks, from 12 to 33 mm Hg (median, 29 mm Hg) at 6 months, and from 12 to 29 mm Hg (median, 27 mm Hg) at 12 months. Twelve months after surgery, mean intraocular pressure reduction of 20 mm Hg was statistically significant (P = .020).

CONCLUSION

Ciliary body endophotocoagulation during pars plana vitrectomy may be an effective treatment for pediatric patients with simultaneous uncontrolled glaucoma and vitreoretinal disorders.

摘要

目的

探讨在儿童药物治疗无法控制的青光眼患者行玻璃体切除术中睫状体光凝术的疗效。

方法

我们比较了5例年龄在10个月至14.5岁之间的患者的5只眼睛,这些眼睛在玻璃体切除术中接受了180度睫状体光凝术,比较了术前和术后的眼压及视力。

结果

青光眼药物治疗的术前眼压范围为30至55毫米汞柱(中位数为35毫米汞柱)。术后随访时间为12至24个月,中位数为16个月。药物治疗的术后眼压在6周时为12至35毫米汞柱(中位数为25毫米汞柱),6个月时为12至33毫米汞柱(中位数为29毫米汞柱),12个月时为12至29毫米汞柱(中位数为27毫米汞柱)。术后12个月,平均眼压降低20毫米汞柱,具有统计学意义(P = 0.020)。

结论

玻璃体切除术中的睫状体光凝术可能是治疗同时患有无法控制的青光眼和玻璃体视网膜疾病的儿童患者的有效方法。

相似文献

1
Ciliary body endophotocoagulation during pars plana vitrectomy for pediatric patients with vitreoretinal disorders and glaucoma.在为患有玻璃体视网膜疾病和青光眼的儿科患者进行玻璃体切割术时进行睫状体眼内光凝术。
Am J Ophthalmol. 1998 Nov;126(5):723-5. doi: 10.1016/s0002-9394(98)00184-6.
2
Ciliary body endophotocoagulation during pars plana vitrectomy in eyes with vitreoretinal disorders and concomitant uncontrolled glaucoma.玻璃体视网膜疾病合并未控制青光眼患者在玻璃体切割术中进行睫状体光凝术。
Ophthalmology. 1996 Jul;103(7):1041-6. doi: 10.1016/s0161-6420(96)30569-1.
3
Aqueous tube-shunt implantation and pars plana vitrectomy in eyes with refractory glaucoma.难治性青光眼患者的房水引流管植入术和平坦部玻璃体切除术
Am J Ophthalmol. 1993 Aug 15;116(2):189-95. doi: 10.1016/s0002-9394(14)71284-x.
4
Management of glaucoma implants occluded by vitreous incarceration.玻璃体嵌顿所致青光眼植入物的处理
J Glaucoma. 2000 Aug;9(4):311-6. doi: 10.1097/00061198-200008000-00005.
5
Combined pars plana vitrectomy and glaucoma drainage implant placement for refractory glaucoma.玻璃体切割联合青光眼引流植入物植入治疗难治性青光眼。
Am J Ophthalmol. 2000 Mar;129(3):334-41. doi: 10.1016/s0002-9394(99)00363-3.
6
Acrylic intraocular lens placement in conjunction with pars plana vitrectomy.丙烯酸人工晶状体植入联合玻璃体切除术。
Am J Ophthalmol. 2001 Jun;131(6):748-50. doi: 10.1016/s0002-9394(01)00835-2.
7
Transvitreal endocyclophotocoagulation.经玻璃体腔内睫状体光凝术
Trans Am Ophthalmol Soc. 1996;94:589-676.
8
Clinical Efficacy of Ciliary Ring Incision Combined with Modified Partial Pars Plana Vitrectomy for Malignant Glaucoma.睫状体环扎联合改良部分睫状体平坦部玻璃体切除术治疗恶性青光眼的临床疗效。
Med Sci Monit. 2018 Jun 10;24:3916-3921. doi: 10.12659/MSM.910672.
9
[Therapeutic effect of laser photocoagulation of ciliary processes in aphakic glaucoma].[激光光凝睫状体治疗无晶状体性青光眼的疗效]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007 May;36(3):303-6. doi: 10.3785/j.issn.1008-9292.2007.03.016.
10
Pars plana vitrectomy, endolaser coagulation of the retina and the ciliary body combined with silicone oil endotamponade in the treatment of uncontrolled neovascular glaucoma.玻璃体切割术、视网膜及睫状体眼内激光光凝联合硅油眼内填充治疗难治性新生血管性青光眼
Graefes Arch Clin Exp Ophthalmol. 1999 Dec;237(12):969-75. doi: 10.1007/s004170050332.